This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
DETROIT, April 26, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to provide the following update to shareholders highlighting our progress and our vision for the year 2013.
We continue to follow our core strategy of developing a diversified investment of nanotechnologies for our shareholders in Nano Labs.
Our core strategy is founded on four main ideals: first, identify and prioritize the obvious problems that we face in the world today; second, to concentrate our resources on developing our proprietary nano technology to evolve common products into new, revolutionary products in order to solve these problems; third, to leverage our international business contacts and networks to introduce these novel solutions to existing problems; and fourth, to work with strategic partners on commercializing these high-value solutions being brought to market in a timely fashion. We're confident that we will continue to create value for our shareholders by executing this core strategy.
Our teams of scientists, designers, and engineers remain focused on creating a portfolio of advanced products that will provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. We are continuing to create products in these industries to provide us the ability to generate revenues from different market sectors, and our hard work we believe is close to yielding significant results.
We have had many exciting highlights this year to date and I would like to take a moment and share my insights on these with you.
Our important partnerships are a testament to our core strategy. Most notably, we are extremely pleased with the advances in our partnership with CIATEQ. They have proven to be a key cornerstone in our company development. We have made exciting progress in creating solutions, prototypes and testing of several new products in the nano medicine, antiviral and pharma applications that we are excited to reveal in the near future. Testing products takes time, but every day we get closer. The upcoming quarter will be an exciting one. Of note, our marketing team has posted a CIATEQ video which is featured on the home page of our website, and I invite you to view it. Currently, we employ four full time employees at the CIATEQ facilities in Queretaro and twenty-one post grad employees under the direction of Dr. Castano working at CIATEQ and our universities facilities.